Kairos Pharma, LTD. — Form D
Kairos Pharma, LTD. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-27. The offering totals $3.0M, of which $675K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-04-27
- Form: D
- Accession: 0001493152-23-013724
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $675K
- Remaining: $2.3M
- Minimum investment: $25K
- Investors: 9
- Date of first sale: 2022-06-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-480119
Issuer
- Name: Kairos Pharma, LTD.
- CIK: 0001962011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2355 WESTWOOD BLVD., #139, LOS ANGELES, CA, 90064
- Phone: (310) 948-2356
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Hyun Bae | Director | Del Mar, CA |
| John Yu | Director | Cambridge, MA |
| Neil Bhowmick | Executive Officer | Los Angeles, CA |
| Ramachandran Murali | Executive Officer | Los Angeles, CA |
| Doug Samuelson | Executive Officer | Westlake Village, CA |
| John Yu | Executive Officer | Cambridge, MA |
| Hyun W Bae | Director | Los Angeles, CA |
| Neil S Bhowmick | Executive Officer | Los Angeles, CA |
| John S Yu | Director | Los Angeles, CA |
| John S Yu | Executive Officer | Los Angeles, CA |
| Hansoo Michael W Keyoung | Director | Los Angeles, CA |
| Ramachandran S Murali | Executive Officer | Los Angeles, CA |
| Doug S Samuelson | Executive Officer | Los Angeles, CA |
| Rahul W Singhvi | Director | Los Angeles, CA |
Other filings by this issuer (1)
More